390 related articles for article (PubMed ID: 23307348)
1. Drug delivery systems for the treatment of ischemic stroke.
Rhim T; Lee DY; Lee M
Pharm Res; 2013 Oct; 30(10):2429-44. PubMed ID: 23307348
[TBL] [Abstract][Full Text] [Related]
2. Stroke and Drug Delivery--In Vitro Models of the Ischemic Blood-Brain Barrier.
Tornabene E; Brodin B
J Pharm Sci; 2016 Feb; 105(2):398-405. PubMed ID: 26869407
[TBL] [Abstract][Full Text] [Related]
3. Targeting vascular inflammation in ischemic stroke: Recent developments on novel immunomodulatory approaches.
Shekhar S; Cunningham MW; Pabbidi MR; Wang S; Booz GW; Fan F
Eur J Pharmacol; 2018 Aug; 833():531-544. PubMed ID: 29935175
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic strategy against ischemic stroke with the concept of neurovascular unit.
Ozaki T; Nakamura H; Kishima H
Neurochem Int; 2019 Jun; 126():246-251. PubMed ID: 30946849
[TBL] [Abstract][Full Text] [Related]
5. Applications of Liposomal Drug Delivery Systems to Develop Neuroprotective Agents for the Treatment of Ischemic Stroke.
Fukuta T; Ishii T; Asai T; Oku N
Biol Pharm Bull; 2019; 42(3):319-326. PubMed ID: 30828062
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator.
Shimada Y; Shimura H; Tanaka R; Yamashiro K; Koike M; Uchiyama Y; Urabe T; Hattori N
PLoS One; 2018; 13(5):e0198039. PubMed ID: 29795667
[TBL] [Abstract][Full Text] [Related]
7. Intranasal delivery of progesterone after transient ischemic stroke decreases mortality and provides neuroprotection.
Fréchou M; Zhang S; Liere P; Delespierre B; Soyed N; Pianos A; Schumacher M; Mattern C; Guennoun R
Neuropharmacology; 2015 Oct; 97():394-403. PubMed ID: 26079443
[TBL] [Abstract][Full Text] [Related]
8. Blood-brain barrier drug targeting enables neuroprotection in brain ischemia following delayed intravenous administration of neurotrophins.
Pardridge WM
Adv Exp Med Biol; 2002; 513():397-430. PubMed ID: 12575830
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotection in experimental stroke with targeted neurotrophins.
Wu D
NeuroRx; 2005 Jan; 2(1):120-8. PubMed ID: 15717063
[TBL] [Abstract][Full Text] [Related]
10. Hemorrhagic transformation after ischemic stroke in animals and humans.
Jickling GC; Liu D; Stamova B; Ander BP; Zhan X; Lu A; Sharp FR
J Cereb Blood Flow Metab; 2014 Feb; 34(2):185-99. PubMed ID: 24281743
[TBL] [Abstract][Full Text] [Related]
11. Neurovascular Unit Protection From Cerebral Ischemia-Reperfusion Injury by Radical-Containing Nanoparticles in Mice.
Hosoo H; Marushima A; Nagasaki Y; Hirayama A; Ito H; Puentes S; Mujagic A; Tsurushima H; Tsuruta W; Suzuki K; Matsui H; Matsumaru Y; Yamamoto T; Matsumura A
Stroke; 2017 Aug; 48(8):2238-2247. PubMed ID: 28655813
[TBL] [Abstract][Full Text] [Related]
12. Novel approaches for the delivery of therapeutics in ischemic stroke.
Nozohouri S; Sifat AE; Vaidya B; Abbruscato TJ
Drug Discov Today; 2020 Mar; 25(3):535-551. PubMed ID: 31978522
[TBL] [Abstract][Full Text] [Related]
13. Injury and repair mechanisms in ischemic stroke: considerations for the development of novel neurotherapeutics.
Candelario-Jalil E
Curr Opin Investig Drugs; 2009 Jul; 10(7):644-54. PubMed ID: 19579170
[TBL] [Abstract][Full Text] [Related]
14. The erythropoietin-derived peptide MK-X and erythropoietin have neuroprotective effects against ischemic brain damage.
Yoo SJ; Cho B; Lee D; Son G; Lee YB; Soo Han H; Kim E; Moon C; Moon C
Cell Death Dis; 2017 Aug; 8(8):e3003. PubMed ID: 28817120
[TBL] [Abstract][Full Text] [Related]
15. Drug delivery to the ischemic brain.
Thompson BJ; Ronaldson PT
Adv Pharmacol; 2014; 71():165-202. PubMed ID: 25307217
[TBL] [Abstract][Full Text] [Related]
16. Salvaging brain ischemia by increasing neuroprotectant uptake via nanoagonist mediated blood brain barrier permeability enhancement.
Zheng S; Bai YY; Liu Y; Gao X; Li Y; Changyi Y; Wang Y; Chang D; Ju S; Li C
Biomaterials; 2015 Oct; 66():9-20. PubMed ID: 26188608
[TBL] [Abstract][Full Text] [Related]
17. [Development of DDS Actively to Overcome the Blood-brain Barrier in the Region of Ischemic Stroke].
Fukuta T; Kogure K
Yakugaku Zasshi; 2020; 140(8):1007-1012. PubMed ID: 32741858
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective Effect of VEGF-Mimetic Peptide QK in Experimental Brain Ischemia Induced in Rat by Middle Cerebral Artery Occlusion.
Pignataro G; Ziaco B; Tortiglione A; Gala R; Cuomo O; Vinciguerra A; Lapi D; Mastantuono T; Anzilotti S; D'Andrea LD; Pedone C; di Renzo G; Annunziato L; Cataldi M
ACS Chem Neurosci; 2015 Sep; 6(9):1517-25. PubMed ID: 26173041
[TBL] [Abstract][Full Text] [Related]
19. Targeted delivery of growth factors in ischemic stroke animal models.
Rhim T; Lee M
Expert Opin Drug Deliv; 2016; 13(5):709-23. PubMed ID: 26788902
[TBL] [Abstract][Full Text] [Related]
20. Targeted delivery of intranasally administered nanoparticles-mediated neuroprotective peptide NR2B9c to brain and neuron for treatment of ischemic stroke.
Li R; Huang Y; Chen L; Zhou H; Zhang M; Chang L; Shen H; Zhou M; Su P; Zhu D
Nanomedicine; 2019 Jun; 18():380-390. PubMed ID: 30428334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
